UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

Arthritis research & therapy, 2020-03, Vol.22 (1), p.56-8, Article 56

2020

Volltextzugriff (PDF)

Outcomes of conventionally-treated systemic sclerosis patients eligible for autologous haematopoietic stem cell transplantation

Clinical and Experimental Rheumatology, 2021-07, Vol.39 Suppl 131 (4), p.29-33

2021

Volltextzugriff (PDF)

THU0429 Nailfold video capillaroscopy and deterioration of skin involvement and lung function tests in systemic sclerosis: a 3-year prospective study

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.427

2018

Volltextzugriff (PDF)

AB0745 Mechanics of early ventricular impairment in systemic sclerosis and the effects of peripheral vasculopathy

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1510

2018

Volltextzugriff (PDF)

THU0355 PARAMETRIC CARDIAC MAGNETIC RESONANCE IMAGING IDENTIFIES ARRHYTHMOGENIC SUBSTRATES IN SYSTEMIC SCLEROSIS PATIENTS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.409-409

2020

Volltextzugriff (PDF)

Absence of radiographic progression of hip arthritis during infliximab treatment for ankylosing spondylitis

Clinical rheumatology, 2013-08, Vol.32 (8), p.1229-1232

2013

Volltextzugriff (PDF)

FRI0440 Increased Messenger RNA Levels of the Mesenchymal Cadherin-11 in the Peripheral Blood Correlate with Diffuse Skin Involvement in Systemic Sclerosis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.586-586

2015

Volltextzugriff (PDF)

FRI0376 Beneficial effect of buspirone, an orally available 5-ht1a receptor agonist, on lower esophageal sphincter function in patients with systemic sclerosis

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A500-A500

2013

Volltextzugriff (PDF)

SAT0128 Biologic Treatment is Associated with More Serious Adverse Reactions, Serious Infections and Admissions in Hospital than DMARDS in Patients with Rheumatoid Arthritis: A REAL World Study

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.637-637

2014

Volltextzugriff (PDF)

THU0243 Proper Initiation of Biologic Treatment (TREAT-TO-TARGET STRATEGY) Favors Better Outcome in Patients with Rheumatoid Arthritis

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.266-266

2014

Volltextzugriff (PDF)

FRI0001 Good Response after Three Months of Treatment with Biologic Agents May PREDICT Long-Term Efficacy of Biologic Treatment in Patients with Rheumatoid Arthritis

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.381-381

2014

Volltextzugriff (PDF)

H1N1 influenza outcome in rheumatic patients under biological therapy

Clinical and experimental rheumatology, 2012-03, Vol.30 (2), p.311

2012

Volltextzugriff (PDF)

AB0553 THE NOCEBO PHENOMENON PARTLY ACCOUNTS FOR DIARRHOEA AMONG PARTICIPANTS IN THE RANDOMIZED PLACEBO-CONTROLLED TRIAL OF NINTEDANIB FOR INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS (SENSCIS)

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1573-1573

2020

Volltextzugriff (PDF)

POS0894 ANTI-IL-6 THERAPY EFFECT FOR REFRACTORY JOINT AND SKIN INVOLVEMENT IN SYSTEMIC SCLEROSIS: A REAL-WORLD, SINGLE CENTER EXPERIENCE

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.703-703

2021

Volltextzugriff (PDF)

Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world study

Clinical and experimental rheumatology, 2015-03, Vol.33 (2), p.216

2015

Volltextzugriff (PDF)

FRI0410 Predictors of morbidity and mortality in patients with early systemic sclerosis: long-term follow-up from a single centre inception cohort study

Annals of the rheumatic diseases, 2017-06, Vol.76 (Suppl 2), p.642

2017

Volltextzugriff (PDF)

Severe oesophageal disease and its associations with systemic sclerosis

Clinical and experimental rheumatology, 2017-09, Vol.35 Suppl 106 (4), p.82

2017

Volltextzugriff (PDF)

FRI0414 Can echocardiography replace follow-up cardiac catheterization in re-evaluation of pulmonary arterial hypertension? a longitudinal single-center study of 30 connective tissue disease patients

Annals of the rheumatic diseases, 2017-06, Vol.76 (Suppl 2), p.643

2017

Volltextzugriff (PDF)

Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database

Clinical and experimental rheumatology, 2017-07, Vol.35 (4), p.579

2017

Volltextzugriff (PDF)

Do non-steroidal anti-inflammatory drugs increase or decrease cardiovascular risk in patients with rheumatoid arthritis?

Clinical and experimental rheumatology, 2014-11, Vol.32 (6 Suppl 87), p.S

2014

Volltextzugriff (PDF)

THU0028 Type i interferon signature in the peripheral blood and CXCL4 plasma levels in patients with systemic sclerosis

Annals of the rheumatic diseases, 2017-06, Vol.76 (Suppl 2), p.210

2017

Volltextzugriff (PDF)

Increased messenger RNA levels of the mesenchymal cadherin-11 in the peripheral blood of systemic sclerosis patients correlate with diffuse skin involvement

Clinical and experimental rheumatology, 2015-07, Vol.33 (4 Suppl 91), p.S36

2015

Volltextzugriff (PDF)

Therapeutic Inhibition of Tyrosine Kinases in Systemic Sclerosis: A Review of Published Experience on the First 108 Patients Treated with Imatinib

Seminars in arthritis and rheumatism, 2013-02, Vol.42 (4), p.377-390

2013

Volltextzugriff (PDF)

SAT0361 Chest computed tomography as an alternative to high resolution manometry for the diagnosis of scleroderma esophagus

Annals of the rheumatic diseases, 2017-06, Vol.76 (Suppl 2), p.908

2017

Volltextzugriff (PDF)

Mycophenolate Versus Cyclophosphamide for Progressive Interstitial Lung Disease Associated with Systemic Sclerosis: A 2-Year Case Control Study

Lung, 2013-10, Vol.191 (5), p.483-489

2013

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

Humans
(13)
Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Systemic Sclerosis
(11)
Female
(9)
Male
(9)
Middle Aged
(9)
Rheumatology
(9)
Scleroderma
(9)
Adult
(8)
Aged
(6)
Retrospective Studies
(6)
Lung Diseases
(5)
Multivariate Analysis
(5)
Risk Factors
(5)
Fibrosis
(4)
Treatment Outcome
(4)
Arthritis, Rheumatoid - Drug Therapy
(3)
Cyclophosphamide - Therapeutic Use
(3)
Echocardiography
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

Outcomes of conventionally-treated systemic sclerosis patients eligible for autologous haematopoietic stem cell transplantation

THU0429 Nailfold video capillaroscopy and deterioration of skin involvement and lung function tests in systemic sclerosis: a 3-year prospective study

AB0745 Mechanics of early ventricular impairment in systemic sclerosis and the effects of peripheral vasculopathy

THU0355 PARAMETRIC CARDIAC MAGNETIC RESONANCE IMAGING IDENTIFIES ARRHYTHMOGENIC SUBSTRATES IN SYSTEMIC SCLEROSIS PATIENTS

Absence of radiographic progression of hip arthritis during infliximab treatment for ankylosing spondylitis

FRI0440 Increased Messenger RNA Levels of the Mesenchymal Cadherin-11 in the Peripheral Blood Correlate with Diffuse Skin Involvement in Systemic Sclerosis

FRI0376 Beneficial effect of buspirone, an orally available 5-ht1a receptor agonist, on lower esophageal sphincter function in patients with systemic sclerosis

SAT0128 Biologic Treatment is Associated with More Serious Adverse Reactions, Serious Infections and Admissions in Hospital than DMARDS in Patients with Rheumatoid Arthritis: A REAL World Study

THU0243 Proper Initiation of Biologic Treatment (TREAT-TO-TARGET STRATEGY) Favors Better Outcome in Patients with Rheumatoid Arthritis

FRI0001 Good Response after Three Months of Treatment with Biologic Agents May PREDICT Long-Term Efficacy of Biologic Treatment in Patients with Rheumatoid Arthritis

H1N1 influenza outcome in rheumatic patients under biological therapy

AB0553 THE NOCEBO PHENOMENON PARTLY ACCOUNTS FOR DIARRHOEA AMONG PARTICIPANTS IN THE RANDOMIZED PLACEBO-CONTROLLED TRIAL OF NINTEDANIB FOR INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS (SENSCIS)

POS0894 ANTI-IL-6 THERAPY EFFECT FOR REFRACTORY JOINT AND SKIN INVOLVEMENT IN SYSTEMIC SCLEROSIS: A REAL-WORLD, SINGLE CENTER EXPERIENCE

Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world study

FRI0410 Predictors of morbidity and mortality in patients with early systemic sclerosis: long-term follow-up from a single centre inception cohort study

Severe oesophageal disease and its associations with systemic sclerosis

FRI0414 Can echocardiography replace follow-up cardiac catheterization in re-evaluation of pulmonary arterial hypertension? a longitudinal single-center study of 30 connective tissue disease patients

Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database

Do non-steroidal anti-inflammatory drugs increase or decrease cardiovascular risk in patients with rheumatoid arthritis?

THU0028 Type i interferon signature in the peripheral blood and CXCL4 plasma levels in patients with systemic sclerosis

Increased messenger RNA levels of the mesenchymal cadherin-11 in the peripheral blood of systemic sclerosis patients correlate with diffuse skin involvement

Therapeutic Inhibition of Tyrosine Kinases in Systemic Sclerosis: A Review of Published Experience on the First 108 Patients Treated with Imatinib

SAT0361 Chest computed tomography as an alternative to high resolution manometry for the diagnosis of scleroderma esophagus

Mycophenolate Versus Cyclophosphamide for Progressive Interstitial Lung Disease Associated with Systemic Sclerosis: A 2-Year Case Control Study

Suchergebnisse filtern